Impact of Personalized Medicine
Personalized medicine is reshaping molecular diagnostics, and the Cell Lysis and Disruption Market is a vital enabler.
In personalized cancer therapies, for example, efficient cell lysis is essential for extracting high-quality DNA, RNA, or proteins from patient-derived samples.
These biomolecules guide treatment selection and monitor therapy response. This growing demand for precise, high-yield extraction methods is influencing both instrument design and reagent formulations in the market.
1 View